Private company
New Enterprise Associates 16, L.P.
American company, incorporated in Delaware. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersDE1
Corporate structure
New Enterprise Associates 16, L.P. sits at the top of its group. 9 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- New Enterprise Associates 16, L.P. DE
- Akouos, Inc. Stake · Boston, Massachusetts
- Allakos Inc. Stake · San Carlos, California, United States
- Black Diamond Therapeutics, Inc. Stake · Cambridge, Massachusetts
- Genocea (United States) Stake · Cambridge
- Marker Therapeutics, Inc. Stake · Houston, Texas
- Metacrine, Inc. Stake · San Diego, California
- Mirum Pharmaceuticals Stake · Foster City, California, United States
- Trevi Therapeutics, Inc. Stake · New Haven, Connecticut
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.
Stakes it holds
New Enterprise Associates 16, L.P. has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).
- Trevi Therapeutics, Inc.SCHEDULE 13D/A Nov 2, 2021 to May 7, 20262
- Marker Therapeutics, Inc.SCHEDULE 13D/A May 17, 2024 to Nov 17, 20253
- Allakos Inc.SCHEDULE 13D/A Oct 11, 2022 to May 16, 20254
- Black Diamond Therapeutics, Inc.SC 13D/A May 13, 20245
- Mirum PharmaceuticalsSC 13D/A Jun 23, 2023 to Dec 29, 20236
- Akouos, Inc.SC 13D/A Oct 28, 20227
- Genocea (United States)SC 13D/A May 27, 20228
- Metacrine, Inc.SC 13D/A Jan 5, 20229
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9